In Vitro Activity of Doripenem against Burkholderia pseudomallei

被引：7
|
作者：
Thamlikitkul, Visanu [1 ]
Trakulsomboon, Suwanna [1 ]
机构：
[1] Mahidol Univ, Siriraj Hosp, Dept Med, Fac Med, Bangkok 10700, Thailand
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2009年 / 53卷 / 07期
关键词：
PSEUDOMONAS-PSEUDOMALLEI; SEVERE MELIOIDOSIS; CEFTAZIDIME; RESISTANCE; SUSCEPTIBILITY; ANTIBIOTICS; MEROPENEM;
D O I：
10.1128/AAC.00893-08
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
The MIC50 and MIC90 values of doripenem, determined by Etest, for 110 isolates of Burkholderia pseudomallei were 0.5 and 0.75 mu g/ml, respectively. There were significant correlations between MICs determined by Etest and MICs determined by agar dilution, MICs determined by Etest and inhibition zone size, and MICs determined by agar dilution and inhibition zone size.
引用
收藏
页码：3115 / 3117
页数：3
相关论文
共 50 条
  • [21] Diffusion and activity of antibiotics against Burkholderia pseudomallei biofilms
    Pibalpakdee, Phannarai
    Wongratanacheewin, Surasakdi
    Taweechaisupapong, Suwimol
    Niumsup, Pannika R.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2012, 39 (04) : 356 - 359
  • [22] In Vitro Susceptibility of Ceftolozane-Tazobactam against Burkholderia pseudomallei
    Chan, Elaine
    Martelli, Paolo
    Hui, Suk-Wai
    Teng, Jade L. L.
    Lau, Susanna K. P.
    Woo, Patrick C. Y.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (05)
  • [23] Ultrastructural effects and antibiofilm activity of LFchimera against Burkholderia pseudomallei
    Puknun, Aekkalak
    Kanthawong, Sakawrat
    Anutrakunchai, Chitchanok
    Nazmi, Kamran
    Tigchelaar, Wikky
    Hoeben, Kees A.
    Veerman, Enno C. I.
    Bolscher, Jan G. M.
    Taweechaisupapong, Suwimol
    [J]. WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY, 2016, 32 (02): : 1 - 10
  • [24] Activity of five fluoroquinolones against 71 isolates of Burkholderia pseudomallei
    Ho, PL
    Cheung, TKM
    Kinoshita, R
    Tse, CWS
    Yuen, KY
    Chau, PY
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 49 (06) : 1042 - 1043
  • [25] Plasmacytoid dendritic cell bactericidal activity against Burkholderia pseudomallei
    Williams, Natasha L.
    Morris, Jodie L.
    Rush, Catherine M.
    Ketheesan, Natkunam
    [J]. MICROBES AND INFECTION, 2015, 17 (04) : 311 - 316
  • [26] Ultrastructural effects and antibiofilm activity of LFchimera against Burkholderia pseudomallei
    Aekkalak Puknun
    Sakawrat Kanthawong
    Chitchanok Anutrakunchai
    Kamran Nazmi
    Wikky Tigchelaar
    Kees A. Hoeben
    Enno C. I. Veerman
    Jan G. M. Bolscher
    Suwimol Taweechaisupapong
    [J]. World Journal of Microbiology and Biotechnology, 2016, 32
  • [27] In Vitro Activity of Doripenem against Burkholderia cepacia Complex Isolates from Non-Cystic Fibrosis Patients
    Singhal, Lipika
    Gautam, Vikas
    Kaur, Mandeep
    Ray, Pallab
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (03) : 1320 - 1321
  • [28] In-vitro activity of β-lactams/trimethoprim-sulfamethoxazole combinations against different strains of Burkholderia pseudomallei
    Mohamad, N., I
    Harun, A.
    Hasan, H.
    Deris, Z. Z.
    [J]. TROPICAL BIOMEDICINE, 2022, 39 (01) : 11 - 16
  • [29] Development of vaccines against Burkholderia pseudomallei
    Patel, Natasha
    Conejero, Laura
    De Reynal, Melanie
    Easton, Anna
    Bancroft, Gregory J.
    Titball, Richard W.
    [J]. FRONTIERS IN MICROBIOLOGY, 2011, 2
  • [30] In vitro activity of levonadifloxacin, the active drug of orally administered prodrug alalevonadifloxacin against bloodstream isolates of Burkholderia pseudomallei
    Bakthavatchalam, Yamuna Devi
    Manokaran, Yuvasri
    Venkatesan, Dhanalakshmi
    Gunasekaran, Karthik
    Manesh, Abi
    Isaac, Barney
    Lal, Binesh
    Prakash, John Jude Antony
    Walia, Kamini
    Veeraraghavan, Balaji
    [J]. CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH, 2024, 26
12345